British
and Irish Legal Information Institute
Freely Available British and Irish Public Legal Information
[
Home]
[
Databases]
[
World Law]
[
Multidatabase Search]
[
Help]
[
Feedback]
England and Wales Court of Appeal (Civil Division) Decisions
You are here:
BAILII >>
Databases >>
England and Wales Court of Appeal (Civil Division) Decisions >>
Smithkline Beecham Plc v Generics (UK) Ltd. [2003] EWCA Civ 1109 (24 July 2003)
URL: http://www.bailii.org/ew/cases/EWCA/Civ/2003/1109.html
Cite as:
[2004] 1 WLR 1479,
[2003] EWCA Civ 1109,
[2004] WLR 1479
[
New search]
[
Printable RTF version]
[Buy ICLR report:
[2004] 1 WLR 1479]
[
Help]
|
|
Neutral Citation Number: [2003] EWCA Civ
1109 |
|
|
Case No:
A3/2003/1441;1451 |
IN THE SUPREME COURT OF JUDICATURE
COURT OF APPEAL (CIVIL
DIVISION)
ON APPEAL FROM CHANCERY DIVISION
MR JUSTICE PUMFREY
|
|
Royal Courts of Justice Strand,
London, WC2A 2LL
|
|
|
24th July
2003 |
B e f o r e :
LORD JUSTICE ALDOUS
LORD JUSTICE CHADWICK
and
LORD
JUSTICE LATHAM
____________________
|
SMITHKLINE BEECHAM PLC
|
Claimant/ Respondent
|
|
- and -
|
|
|
GENERICS (UK)
LIMITED
|
Defendant/Appellant
|
|
AND BETWEEN
|
|
|
BASF AG
|
Claimant/ Respondent
|
|
- and -
|
|
|
SMITHKLINE BEECHAM
PLC
|
Defendant/Appellant
|
____________________
(Transcript of the Handed Down Judgment of
Smith
Bernal Wordwave Limited, 190 Fleet Street
London EC4A 2AG
Tel No: 020 7421
4040, Fax No: 020 7831 8838
Official Shorthand Writers to the Court)
____________________
Mr Justin Turner and Geoffrey Pritchard (instructed by Simmons &
Simmons) for the Appellants
Mr Simon Thorley QC and Thomas Hinchliffe
(instructed by S.J. Berwin) for the Respondents
____________________
HTML VERSION OF JUDGMENT
____________________
Crown Copyright ©
Lord Justice Aldous:
- There are before the court two appeals against
orders of Pumfrey J which had the effect of preventing SmithKline Beecham Plc
(SB) from using certain documents in their case against Apotex which is
currently before the judge. Before coming to the issues raised in the appeals
it is necessary to set out the background.
- SB are the patentees of UK patent no. 2247550
relating to a process for producing paroxetine hydrochloride anhydrate (PHA).
That is a pharmaceutical sold in large quantities by SB.
- Back in 2001 SB started proceedings against Generics
(UK) Limited for infringement of the patent. Generics denied infringement and
alleged that the patent was invalid. Around the same time BASF AG commenced
proceedings to revoke the patent upon similar grounds to those raised by
Generics in their attack upon validity.
- One of the main contentions of BASF and Generics was
that the patent lacked novelty and was obvious having regard to the disclosure
in the SB application no. 85-26407 (407). Example 1 of 407 contained details
of how to produce PHA and it was contended that that example made available to
the public the invention claimed in claim 11 of the patent or made available a
process of production which. if altered in an obvious way, would result in
PHA. SB contended that if you carried out example 1 of 407, PHA was not
obtained and that the alteration needed to produce PHA was not obvious.
- Example 1 of 407 set out a recipe for obtaining PHA.
It included the instruction that the "acetate salt was dissolved in
isopropanol (2.4 litres) and treated with a mixture of hydrochloric acid (75
ml) and more isopropanol". The main dispute between the parties revolved
around how much "more isopropanol" the skilled person would add if he sought
to carry out example 1. BASF and Generics, for reasons that I need not go
into, submitted that about 2 litres of isopropanol would be added. SB's case
was that the amount would be well below 1 litre.
- In his judgment [2002] EWHC 1373 (Ch), the judge
accepted the submission of SB and held that if the notional skilled person
carried out example 1 of 407 he would not obtain PHA and therefore example 1
of 407 did not make available to the public claim 11 of the patent. Thus claim
11 did not lack novelty. He also held that claim 11 was not obvious having
regard to the disclosure in 407. This Court upheld those decisions of the
judge (see [2003] EWCA Civ 872).
- The proceedings against Generics and by BASF were
not consolidated, but they came on for hearing at the same time. On the first
day of the trial, SB and Generics settled their differences and the case was
adjourned to enable the papers to be rearranged. On the second day SB sought
permission to use two sets of documents which had been disclosed by Generics
in the BASF proceedings. I will refer to those documents as the Sumika and
Darmstadt documents respectively. I will come later to the relevance of those
documents and the decision of the judge to allow the documents to be used, but
first must explain how they came to be produced by Generics.
- The Darmstadt documents had initially been referred
to in certain e-mails that had been disclosed in Generics' list of documents.
They were requested by SB's solicitors by letter dated 20th December 2001.
Production was resisted because they were not in the possession of Generics.
They were however obtained from an associated company of Generics and then
produced on about 21st January 2002. They were produced under a cloak of
confidence to those in the "confidentiality club". They were also referred to
in the expert report of Professor Mullin who was to be called as a witness by
Generics. He said:
"96. Finally I have been asked to comment on certain
experimental runs performed, I understand, in a laboratory in Darmstadt in
Germany. I attach a translation of the experiment's notebooks as exhibit JWM
4."
- He went on to make a general comment upon the
disclosure in the documents and expressed an opinion on one point.
- The Sumika documents were also referred to in
Professor Mullin's report. In paragraph 65 of his witness statement he said
that the exact manner in which an addressee might perform example 1 of 407 was
not possible to predict. There were many minor variations in techniques that
different skilled addressees, applying their ordinary general knowledge, might
apply. It was his view that it was not feasible to say what the skilled
addressee would have done, but only what he might have performed. In paragraph
66 he recounted how he had been asked initially to suggest a reasonable
starting point for putting example 1 of 407 into practice. His view was set
out in an annex to his report. He said that it represented his opinion as to
the likely way that the skilled addressee at the relevant date might have
started seeking to produce PHA in accordance with example 1 of 407. He said
his view represented but one logical starting point and it would not have
surprised him if his protocol did not produce PHA in significant quantities
or, possibly, at all. He said that the development of protocols of this type
was part of the routine work of the skilled addressee, but it took time. He
continued:
"I was therefore shown a draft protocol which I was told by S.J.
Berwin [Generic's solicitors] had already been worked up to the produce the
anhydrate. This is in substance the protocol contained in GUK's notice of
experiments (the GUK protocol). I was asked to consider the differences
between it and my protocol. Because of the brief nature of example 1, it
would have been very unlikely if I had chosen precisely the same protocol as
GUK. However for reasons which I set out below, I believe the GUK protocol
represents the type of routine development from my protocol which the
addressee might have devised to perform example 1 if initial experiments had
resulted (wholly or partially) in the production of the hemihydrate."
- Upon receipt of the witness statement of Professor
Mullin, SB's solicitors wrote seeking under CPR 31.14 the documents referred
to by Professor Mullin. They were provided in February 2002 and were in
substance the Sumika documents. To make them complete certain e-mails were
supplied as requested. Those documents were also provided by Generics under a
cloak of confidence and were therefore only available to those in the
"confidentiality club".
- The judge heard SB's application to be able to
rely upon the documents in the BASF action. It was resisted. In his judgment
he said that his decision depended upon a number of factors. First, whether
they would have been obtainable on an application for discovery against a
third party; second the materiality of the documents; third the strength of
the case of confidentiality and fourth fairness on the party whose documents
they were. He concluded that the interests of the owners of the documents
could be preserved by ensuring the documents were kept confidential. As to
materiality he said:
"To rebut the inference which superficially arises on such facts
may require a large number of small bricks. I do not know – and it would not
be right to speculate any further than that at this stage. I would therefore
be unwilling to exclude a priori any use of these documents provided I was
satisfied that the interests of the owners of those documents were
adequately protected. I believe that I can adequately protect the interests
of the owners of these documents in the way I have indicated and therefore I
am going to give leave for them to be used."
- He therefore admitted SB's documents on terms that
they would be dealt with in private. He made an order over trial under CPR
31.22 (2). They were subsequently used in cross-examination which took place
in private. He referred to them in paragraph 61 of his judgment handed down
after trial. He said:
"61. SB also relied on certain experiments which had been put in
by Generics before the action between them and SB settled. These also, Mr
Waugh QC said, had been carefully "worked up" so as not to represent a fair
repetition. The clear evidence is that the experimenter responsible for
working up these experiments had found that he had obtained the hemihydrate
if concentrated hydrochloric acid was used. He appears to have started by
using comparatively small quantities for "more isopropanol". There was also
evidence of experiments conducted in Germany by associates of Generics which
had the same result."
- Shortly after the judgment in the BASF action,
Generics sought on 17th July 2002 an order that further use of the Sumika and
Darmstadt documents should be permanently prohibited by an order under CPR
31.22 (2) and also that copies should be delivered up to Generics. That
application came before the judge on 25th July 2002 when SB submitted that no
such order should be made. Despite a letter to him reminding him of the need
to give judgment, no judgment was delivered in 2002.
- Whilst the proceedings against BASF were
proceeding, SB started proceedings against Apotex Limited alleging
infringement of the patent. Apotex denied infringement and alleged that the
patent was invalid. Like BASF they contended that the patent lacked novelty
and was obvious having regard to the disclosure in 407. SB say that when they
saw the witness statements provided by Apotex on 23rd May 2003 they realised
the importance of the Sumika and Darmstadt documents to the issues in the
Apotex proceedings. That prompted them to write again to the judge on 30th May
2003 explaining the position and that they considered that it might be
necessary for them to make an application in the Apotex proceedings to allow
them to admit the Sumika and Darmstadt documents. The judge was away when the
letter was received and therefore SB decided it was necessary to make an
application for an order that they should be allowed to use the documents in
the Apotex proceedings. That application was adjourned to come on for hearing
on Monday 30th June 2003. However on 27th June 2003 the judge delivered his
judgment on the Generics application to permanently prevent use of those
documents.
- In his judgment of 27th June 2003 the judge
concluded that it was not necessary that the documents should be disclosed and
in the circumstances he continued the order made under CPR 31.22 (2)
indefinitely. There followed a hearing on SB's application to be allowed to
use the documents in the Apotex proceedings. Judgment was given on 30th June
2003 giving reasons as to why they should not be used. He then dismissed the
application.
- Although both appeals are concerned with the
ability of SB to use the documents, different considerations apply. In the
first appeal SB contend that restrictions on use imposed by the judge under
CPR 31.22(2) should not have been made. If they are right, the documents are
available for use in proceedings in all countries. In the second appeal use is
only sought under conditions of confidence for use in the Apotex proceedings.
The First Appeal
- The judge in his judgment of 27th June referred to
the provisions of CPR 31 and then stated, "I prefer to deal with the question
of the use of these documents as an exercise of my discretion under CPR
31.22(2) on the principles enunciated by the Court of Appeal in Lilly Icos
v Pfizer [2002] 1 AER 842 at 851, [2002] EWCA Civ 2."
- In the Lilly Icos case the patentee had
disclosed to the defendants material in documents designated as confidential
and in consequence it was by agreement between the parties kept confidential
and only seen by those in the confidentiality club. The disclosed material
included a two page schedule showing on its first page the sales figures for
the patentee's product and on the second page the patentee's advertising
expenditure since the product was launched. The documents were intended to be
used to support the patentee's claim that the invention had been a commercial
success. After the trial, all of which had been in public, the patentee made
an unopposed application for an order under CPR 31.22(2) to maintain
confidentiality in respect of the second page of the schedule.
- The judge concluded that since the issue of the
validity of the patent was of general public importance, the party seeking to
withhold material from disclosure had to make out a case that there was a
necessity for such an order. He concluded that no such case had been made out
and he refused to make the order. The patentee appealed. This Court concluded
that the test applied by the judge was not appropriate. At the outset this
Court made these general observations:
"7. Although the principle of the orality of the English trial
remains untouched, practice has moved greatly in the direction of the
presentation of evidence and arguments in writing; the use of documents by
reference to them in those writings rather than by their being read out in
open court; and the consideration by the judge of a large part of that
material before the trial opens, so that it is not necessary to make
specific reference to it during the trial itself. In Smithkline Beecham
Biologicals SA v Connaught Laboratories Inc. [1999] 4 All ER 498
[Connaught] this court pointed out that the intent of (as it was
then) RSC, Ord. 24, r.14A would be substantially frustrated if the rule were
literally restricted to what had physically happened in open court. The rule
was passed in the interests of the publicity properly attaching to the
administration of justice, and of the interests of the recipient of the
document under Article 10 of the European Convention: [1999] 4 All E.R. at
510g. To achieve those ends under modern practice it was necessary to take
as falling under RSC 31.22(1)(a) any document pre-read by the judge, or
referred to in for instance witness statements taken to stand as evidence,
even if the document or the witness statement was not actually read out in
court. Some further details of that regime may be mentioned, and then some
comments offered.
8. First, there are taken to fall under the rule certain
categories of document, in particular those coming within the pre-reading of
the judge. It does not have to be established that the judge has actually
read the documents: once the category is established, it is for a party
alleging that they have not in fact been read to establish that fact,
something that has to be achieved without enquiry of the judge (Barings
v. Coopers & Lybrands [2000] 3 All ER 910 at 53). Second, it
therefore follows that not everything that is disclosed or copied in court
bundles falls under this rule: the Connaught approach is restricted
to documents to which the judge has been specifically alerted, whether by
reference in a skeleton argument or by mention in the "reading guide" with
which judges are now provided at least in patent cases. Third, since the
Connaught approach is based upon the assumed orality of a trial,
documents, however much pre-read by the judge, remain confidential if no
trial takes place, but the application is, for instance, dismissed by
consent, albeit by a decision announced in open court: Connaught at
page 509j.
9. The central theme of these rules is the importance of the
principle that justice is to be done in public, and within that principle
the importance of those attending a public court understanding the case.
They cannot do that if the contents of documents used in that process are
concealed from them: hence the release of confidence once the document has
been read or used in court. As this court recognised in Connaught,
there may be some artificiality about that approach. That is because full
access to documents deemed to have been read or used in court may give third
parties at least the possibility of much more fully studying and
understanding the case and the issues in it than if they merely heard the
documents read aloud. Nevertheless, that paradox helps to underline this
court's concern that economical means of using and referring to the
documents, understood amongst the lawyers, should not exclude the spectators
from comprehension of the case."
- This Court went on to note that the particular
document had been disclosed to a confidentiality club, but that when making
its decision under CPR 31.22(2) at the end of the proceedings, the court,
"will not be constrained by any such confidentiality agreement (see the
Connaught case [1999] 4 AER 498 at 511)." The court's approach was set
out in paragraph 25:
"25. It may be convenient to set out a number of considerations
that have guided us:
(i) The court should start from the principle that very good
reasons are required for departing from the normal rule of publicity. That
is the normal rule because, as Lord Diplock put it in Home Office v
Harman [1983] 1 A.C. 280 at 303C, citing both Jeremy Bentham and Lord
Shaw of Dunfermline in Scott v Scott:
"Publicity is the very soul of justice. It is the keenest spur
to exertion, and the surest of all guards against improbity. It keeps the
judge himself, while trying, under trial."
The already very strong English jurisprudence to this effect has
only been reinforced by the addition to it of this country's obligations
under Articles 6 and 10 of the European Convention.
(ii) When considering an application in respect of a particular
document, the court should take into account the role that the document has
played or will play in the trial, and thus its relevance to the process of
scrutiny referred to by Lord Diplock. The court should start from the
assumption that all documents in the case are necessary and relevant for
that purpose, and should not accede to general arguments that it would be
possible, or substantially possible, to understand the trial and judge the
judge without access to a particular document. However, in particular cases
the centrality of the document to the trial is a factor to be placed in the
balance.
(iii) In dealing with issues of confidentiality between the
parties, the court must have in mind any "chilling" effect of an order upon
the interests of third parties: see paragraph 5 above.
(iv) Simple assertions of confidentiality and of the damage that
will be done by publication, even if supported by both parties, should not
prevail. The court will require specific reasons why a party would be
damaged by the publication of a document. Those reasons will in appropriate
cases be weighed in the light of the considerations referred to in
sub-paragraph (ii) above.
(v) It is highly desirable, both in the general public interest
and for simple convenience, to avoid the holding of trials in private, or
partially in private. In the present case, the manner in which the documents
were handled, together with the confidentiality agreement during trial,
enabled the whole of the trial to be held in public, even though the judge
regarded it as justified to retain confidentiality in respect of a
significant number of those documents after the trial was over. The court
should bear in mind that if too demanding a standard is imposed under CPR
31.22(2) in respect of documents that have been referred to inferentially or
in short at the trial, it may be necessary, in order to protect genuine
interests of the parties, for more trials or parts of trials to be held in
private, or for instance for parts of witness statements or skeletons to be
in closed form.
(vi) Patent cases are subject to the same general rules as any
other cases, but they do present some particular problems and are subject to
some particular considerations. As this court pointed out in
Connaught, patent litigation is of peculiar public importance, as the
present case itself shows. That means that the public must be properly
informed; but it means at the same time that the issues must be properly
explored, in the sense that parties should not feel constrained to hold back
from relevant or potentially relevant issues because of (legitimate) fears
of the effect of publicity. We venture in that connection to repeat some
words of one of our number in Bonzel v. Intervention Ltd [1991]
R.P.C. 231 at 234, paragraph 27: "the duty placed upon the patentee to make
full disclosure of all relevant documents (which is required in amendment
proceedings) is one which should not be fettered by any action of the
courts. Reluctance of this court to go into camera to hear evidence in
relation to documents which are privileged which could be used in other
jurisdictions, would tend to make patentees reluctant to disclose the full
position. That of course would not be in the interest of the
public."
In our view, the same considerations can legitimately be in the
court's mind when deciding whether to withdraw confidentiality from
documents that are regarded by a party as damaging to his interests if used
outside the confines of the litigation in which they were disclosed."
- The judge in his judgment looked at the
considerations referred to in Lilly Icos and concluded, as I have said,
that the balance came down in favour of permanent restriction upon their use.
- Mr Turner, who appeared for SB, submitted that CPR
31.22(2) did not apply to the documents as they had been produced voluntarily
and were referred to in the report of Professor Mullin. The judge had failed
to appreciate that documents produced in that way were not disclosed documents
within CPR 31.22(2). The position under the CPR was the same as existed under
the Rules of the Supreme Court as explained in Derby v Weldon (No. 2),
The Times, 20th October 1990, Prudential Assurance Co. Ltd v Fountain Page
Ltd [1991] QB 771 and Eagle Star Insurance Co Ltd v Arab Bank Plc
(unreported) 25th February 1991. Mr Turner also submitted that the judge had
made material errors in the way that he had applied the considerations
referred to in Lilly Icos.
- Mr Turner's first submission starts from the
regime that applied pre-CPR. It was settled law that documents produced on
discovery were subject to an implied undertaking that they would only be used
for the purposes of the proceedings in which they were disclosed. A rationale
was that discovery was an interference with the right of privacy and therefore
the invasion of that right should be limited to use of the documents in the
proceedings.
- The cases referred to in paragraph 23 established
that voluntary disclosure in the course of proceedings did not come within the
rationale for applying the implied undertaking. Documents included in
affidavits and documents produced pursuant to an order made under Order 24
rules 10 and 11 were not subject to the implied undertaking. Further although
there was a restriction upon the use of witness statements of witnesses of
fact not called, there was no such restriction under Order 38 in respect of
experts' reports.
- It followed, Mr Turner submitted, that pre-CPR,
the expert report of Professor Mullin and the documents referred to in it were
not subject to the implied undertaking and therefore were in the public
domain. Further the Darmstadt documents had been obtained by Generics from a
third party and in consequence had been produced voluntarily with the
consequence that the implied undertaking did not apply.
- Mr Turner then took us to the CPR. He submitted
that CPR 31 expressed the old law in modern terms. His submission involved an
analysis of the relevant parts of CPR 31 which are as follows:
"31.2 Meaning of disclosure
A party discloses a document by
stating that the document exists or has existed.
31.3. Right of inspection of a disclosed document
(1) A party to
whom a document has been disclosed has a right to inspect that document
except where-
(a) the document is no longer in the control of the party who
disclosed it;
(b) the party disclosing the document has a right or a duty
to withhold inspection of it; or
(c) paragraph (2)
applies.
31.4. Meaning of document
In this Part-
"document" means
anything in which information of any description is recorded; and
"copy", in
relation to a document, means anything onto which information recorded in
the document has been copied, by whatever means and whether directly or
indirectly.
31.5. Disclosure limited to standard disclosure
(1) An order to give disclosure is an order to give standard
disclosure unless the court directs otherwise.
(2) The court may dispense with or limit standard
disclosure.
(3) The parties may agree in writing to dispense with or to
limit standard disclosure.
(The court may make an order requiring standard disclosure under
rule 28.3 which deals with directions in relation to cases on the fast track
and under rule 29.2 which deals with case management in relation to cases on
the multi-track)
31.6 Standard disclosure – what documents are to be disclosed
Standard disclosure requires a party to disclose only-
(a) the documents on which he relies; and
(b) the documents
which-
(i) adversely affect his own case;
(ii) adversely affect
another party's case; or
(iii) support another party's case;
and
(c) the documents which he is required to disclose by a
relevant practice direction.
…
31.14 Documents referred to in statements of case etc.
(1) A
party may inspect a document mentioned in-
(a) a statement of case;
(b) a witness statement;
(c) a
witness summary; or
(d) an affidavit.
[At time of application the rule included at (e) experts'
reports. This was revoked and (2) inserted.]
(2) Subject to rule 35.10(4), a party may apply for an order for
inspection of any document mentioned in an expert's report which has not
already been disclosed in the proceedings.
31.5 Inspection and copying of documents-
Where a party has a right to inspect a document-
(a) that party must give the party who disclosed the document
written notice of his wish to inspect it;
(b) the party who disclosed the document must permit inspection
not more than 7 days after the date on which he received the notice;
and
(c) that party may request a copy of the document and, if he
also undertakes to pay reasonable copying costs, the party who disclosed the
document must supply him with a copy not more than 7 days after the date on
which he received the request.
(Rule 31.3 and 31.14 deal with the right of a
party to inspect a document)
…
31.17 Orders for disclosure against a person not a
party
(1) This rule applies where an application is made to the court
under any Act for disclosure by a person who is not a party to the
proceedings.
(2) The application must be supported by evidence.
(3) The court may make an order under this rule only
where-
(a) the documents of which disclosure is sought are likely to
support the case of the applicant or adversely affect the case of one of
the other parties to the proceedings; and
(b) disclosure is necessary in order to dispose fairly of the
claim or to save costs.
(4) An order under this rule must-
(a) specify the documents or the classes of documents which
the respondent must disclose; and
(b) require the respondent, when making disclosure, to specify
any of those documents-
(i) which are no longer in his control;
or
(ii) in respect of which he claims a right or duty to withhold
inspection.
(5) Such an order may-
(a) require the respondent to indicate what has happened to
any documents which are no longer in his control;
and
(b) specify the time and place for disclosure and
inspection.
…
31.22 Subsequent use of disclosed documents
(1) A party to whom
a document has been disclosed may use the document only for the purpose of
the proceedings in which it is disclosed, except where-
(a) the document has been read to or by the court, or referred
to, at a hearing which has been held in public;
(b) the court gives
permission; or
(c) the party who disclosed the document and the person to
whom the document belongs agree.
(2) The court may make an order restricting or prohibiting the
use of a document which has been disclosed, even where the document has been
read to or by the court, or referred to, at a hearing which has been held in
public.
(3) An application for such an order may be made-
(a) by a party; or
(b) by any person to whom the document
belongs."
- Mr Turner accepted that CPR 31.22 was a complete
code. The first 25 words were a substitute for the implied undertaking that
applied pre-CPR. CPR 31.22(1)(a), (b) and (c) contained exceptions which also
applied pre-CPR. CPR 31.22 (2) enabled the court to make a restriction or
prohibition order in respect of a document "which has been disclosed …". Such
documents are those produced pursuant to the obligation of disclosure under
such rules as CPR 31.5 and 31.6. There was a difference between a document
which had been disclosed and one which a party had a right to inspect. CPR
31.14 gave a right to inspect documents. At the date of the application the
rule included a right to inspect documents referred to in experts' reports.
That difference between documents disclosed and those which could be inspected
perpetuated the difference which existed under the R.S.C between documents
produced on discovery which were subject to the implied undertaking and those
which had to be produced or were produced voluntarily and those which were
not. It followed that documents were produced voluntarily or in experts'
reports were not documents "which have been disclosed" and therefore the court
did not have power to restrict their use under CPR 31.22(2).
- I agree with Mr Turner that CPR 31 is a complete
code, but I reject his submission that that code perpetuated in all respects
the distinction between documents disclosed in a list of documents and those
that might be disclosed in another way. The obligation to disclose and the
ability to inspect are dealt with separately as is the ability to use a
document after disclosure. CPR 31.3 is concerned with disclosed documents but
reserves an ability to refuse inspection. CPR 31.14 adds to CPR 31.3. In any
case the wide definition in CPR 31.2 must be determinative. That states that:
"A party discloses a document by stating that the document exists or has
existed." No distinction is sought to be drawn between documents obtained from
third parties and no limitation is placed on the way that the statement is
made. In my view a reference by a party to a document in a witness statement
is a statement that the document exists. I therefore reject Mr Turner's
submission. It follows that the judge was right to consider the application by
Generics as an application under CPR 31.22(2). He was also right to conclude
that Lilly Icos gave guidance as to the considerations he should have
in mind.
- The basis of the judge's judgment of 27th June was
in the last two paragraphs.
"27. In carrying out the balancing exercise identified by Buxton
LJ in the passage to which I have referred, I take the following into
account. First, the subject matter of the documents is confidential. Second,
they originate with third parties. Third, they are of peripheral relevance
at best to explain the issues in the action. Fourthly, they are not part of
the material which is needed to explain the judgment. Fifthly, they are not
needed to explain the judgment of the Court of Appeal which does not refer
to them. Sixthly, they cannot be explained without considerable context or
speculation exposing their makers or the employers of their makers to
further requests for further information.
28. I keep at the forefront of my considerations the interests
of public justice. Nevertheless, it seems to me that these documents do not
require to be disclosed and in the circumstances I propose to continue the
order made under CPR 31.22 indefinitely accordingly."
- Mr Turner criticised each of those considerations.
He took us to the documents for the purpose of showing us that the documents
did not contain any information which would be of assistance to a third party
except in litigation. He may be right, but the documents have the quality of
confidence such that a court would restrict disclosure of them.
- Mr Turner challenged the judge's conclusion that
the documents were of peripheral relevance at best to the issues and were not
part of the material needed to explain the judgment. In my view the judge's
description of the documents may be apt. However that does not mean that they
could not be one element that supported the case of SB. As the judge said in
his judgment given on 15th March 2002 when allowing the documents to be used
in the BASF proceedings – "To resist the inference which superficially arises
on such facts [the facts stated in example 1 of 407] may require a large
number of bricks." (see paragraph 12 above).
- In my view the judge was right in paragraph 28 of
his judgment to have in the forefront of his consideration the interests of
both the public and the third parties and the requirements to do justice and
thereafter to conclude that it was not necessary that they should be
disclosed. I believe he was right to make the order under CPR 31.22 that he
did.
The Second Appeal
- The parties agree that despite the order made by
the judge pursuant to his judgment of 27th June 2003, it was open to him to
release them for use in the Apotex proceedings.
- Mr Thorley QC who appeared for Generics supported
the conclusion and reasoning of the judge. As the judge recorded Mr Thorley
put at the forefront of his argument this passage from the judgment of
Whitford J in Halcon International Inc v. Shell Transport and Trading
Co. [1979] RPC 97 at page 109:
"However, these authorities to my mind, lead to this conclusion,
that the use of a document disclosed in a proceeding in some other context,
or even in another proceeding between the same parties in the same
jurisdiction, is an abuse of process unless there are very strong grounds
for making an exception to the general rule. It does, I think, emerge that
some overriding public interest might be a good example, but not the mere
furtherance of some private interest even where that private interest arises
directly out of or is brought to light as a result of the discovery made."
- At paragraph 22 of his judgment the judge said
that the dictum of Whitford J had not, so far as the researches of counsel had
been able to reveal, ever been doubted or disapproved. However that statement
was not followed by the House of Lords in Crest Homes Plc v Marks
[1987] AC 829 at 860. Lord Oliver said:
"Your Lordships have been referred to a number of reported cases
in which application has been made for the use of documents obtained under
Anton Piller orders or on general discovery for the purpose of
proceedings other than those in which the order was made. Examples were
Halcon International Inc. v. Shell Transport and Trading Co. [1979]
R.P.C. 97 and Sybron Corporation v. Barclays Bank Plc [1985] Ch. 299.
I do not, for my part, think that it would be helpful to review these
authorities for they are no more than examples and they illustrate no
general principle beyond this, that the court will not release or modify the
implied undertaking given on discovery save in special circumstances and
where the release or modification will not occasion injustice to the person
giving discovery. As Nourse L.J. observed in the course of his judgment in
the instant case (ante, p.840G), each case must turn on its own individual
facts."
- The Halcon case was considered by Laddie J
together with the other relevant authorities in Cobra Golf Inc v Rata
[1996] FSR 819. The guidance he gave as to the matters the court will include
in its considerations is useful. However it is important under the CPR to have
in mind the overriding principles when considering whether to lift an order
made under CPR 31.22. The most important consideration must be the interest of
justice which involves considering the interest of the party seeking to use
the documents and that of the party protected by the CPR 31.22 order. As Lord
Oliver said each case will depend upon its own facts. But a material
consideration must be whether the documents could have been obtained under CPR
31.17. That rule enables the court to order disclosure from the third parties
if the documents were likely to support SB's case and disclosure was necessary
in order to dispose fairly of the claim.
- SB are clear that the documents support their case
in rebutting the attack by Apotex on their patent. They pointed to the fact
that they were considered by the judge to be of some relevance to SB's case as
he referred to them in his judgment (see paragraph 13 above). However in a
later judgment he said that they were at best of peripheral importance. He
went on to say:
"I would feel extremely diffident about placing any great
reliance upon those documents and the experiments they report without having
heard, as witnesses, the people who were responsible for them. The documents
are potentially embarrassing and their probative value is limited for that
reason."
- In that passage the judge seems to accept that
some reliance could be placed on the documents as a support even though their
probative value was limited. That was consistent with the view that he had
already expressed. It is also consistent with paragraph 61 of his judgment in
the BASF action (see paragraph 13 above). I am not sure why the judge
concluded that the documents were potentially embarrassing. He did not make
that point in his judgment in the BASF proceedings. I suspect that their
usefulness could be in cross-examination and perhaps as a small brick to
support the views expressed by SB's witnesses. That being so, there is a basis
for the submission that the requirements of CPR 31.17(3)(a) could be
satisfied.
- The judge in his judgment allowing use of the
documents in the BASF proceedings made it clear that an appropriate order
could protect the interests of the owners of the documents. It seems that he
was right. Despite the evidence which suggests prejudice, there is no reason
to think that their interests could not be protected by a similar order in the
Apotex proceedings to that made in the BASF proceedings.
- The present case is peculiar in that the judge who
heard the BASF proceedings and considered the documents is hearing the Apotex
proceedings. That presents particular difficulties as he considered the
documents in the BASF case and mentioned them in his judgment. However his
recent judgments suggest that he believed that they were at best of little
relevance to the issues in the Apotex proceedings. That of course must be a
provisional view as the case is still proceeding.
- Even so, the knowledge of the judge presents a
problem. Can the judge both put out of his mind and be seen to put out of his
mind the documents? If the judge finds in favour of SB, Apotex could be left
with a real suspicion that the documents had been a brick in the reasoning,
perhaps unconscious reasoning, of the judge.
- The interest of justice are paramount. In the
present case, the interest of the owners of the documents can be protected by
an order under CPR 31.22. The interests of SB favours modification of the
order made in the Generics proceedings to allow the documents to be deployed
in the Apotex proceedings. There is a real argument that they would be
discoverable under CPR 31.17 and refusal of use could reflect adversely on the
administration of justice. In those circumstances I conclude that the
documents should be released from the CPR 31.22(2) order for use in the Apotex
proceedings with an order protecting the interests of the owners of the
documents in the way that the judge did in the BASF proceedings. That the
judge did in the BASF proceedings.
- I would allow the appeal and make an order similar
to that made by the judge in the BASF proceedings.
Lord Justice Chadwick
- I agree that the first appeal should be dismissed,
for the reasons given by Lord Justice Aldous. I agree, also, that the second
appeal should be allowed, on the basis that the interests of the owners in
preserving the confidentiality of their documents can adequately be protected
by the order which he has proposed. Like him, I take the view that, in the
unusual circumstances that the judge has already considered the documents in
the BASF proceedings, confidence in the administration of justice requires
that they should be available to be deployed in the present proceedings.
Lord Justice Latham:
- I agree.
Order; First appeal dismissed with costs, to be the subject of
detailed assessment if not agreed; second appeal allowed with an order made in
the terms as agreed between the parties; counsel to lodge a draft minute of
order.
(Order does not form part of the approved judgment)